Clinical Trial Detail

NCT ID NCT03560531
Title A Study of ZN-c5 in Subjects With Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors Zeno Alpha Inc.
Indications

Her2-receptor negative breast cancer

Therapies

Palbociclib + ZN-c5

ZN-c5

Age Groups: adult senior

Additional content available in CKB BOOST